India

SII Expands Covovax Paediatric Trial, Aims To Include Kids Aged 2-6

SII will be submitting the interim trial findings on immunogenicity after three months of the advanced clinical trial for licensure

Source: Top India News- News18.com

Horoscope Today, November 18, 2021: Check Out Daily Astrological Prediction for Aries, Taurus, Libra, Sagittarius And Other Zodiac Signs

Centre Plans First Dose for All by 1st Week of December through ‘Har Ghar Dastak’ Campaign

Kerala Octogenarian Dies in Hospital 6 Weeks After Fatally Hitting Wife

“Uzbeks Sent by Iran” Killed Chabad Rabbi in UAE, Fled to Turkey? Israel Vows to Hunt Down “Killers”

IPL Auction 2025 | Rishabh Pant Becomes Most Expensive Player, Breaks Shreyas Iyer’s Record | N18S

Russia ‘Recruits’ Yemeni Mercenaries To Fight In Ukraine As EU Mulls Sending Taurus Missiles To Kyiv

Hamas Says Hostage “Killed in IDF Strike”, IDF on “Outskirts of Litani River”, Bombs Syria Crossing

Man Brutally Kicked And Punched Over Parking Row In Ghaziabad | Video